Gynov

Curated by Signal

Developer of pharmaceuticals and dietary supplements for women health

Overview

Developer of pharmaceuticals and dietary supplements for women health. The company has developed a portfolio of products for women's health, male infertility, and pediatric care. The company's lead product is Isitol, the dietary supplement targeting male infertility, and other products include Gynositol and Gynoferrin for iron deficiency and PCOS of women.

Key facts

Founded: 2016
Headquarters: Bordeaux, France
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

QuantaCell
Image processing, data analysis, consulting and software development services for biological applications
Life Sciences TechnologyPessac, France
Suricog
Provider of eye-tracking solutions for diagnosis and monitoring of neurological disorders
Life Sciences TechnologyParis, France
MediWAT
Developer of a medical device for fall prevention in elderly people
Life Sciences TechnologyFamars, France

About Gynov

What does Gynov do?

Developer of pharmaceuticals and dietary supplements for women health.

Where is Gynov headquartered?

Gynov is headquartered in Bordeaux, France.

When was Gynov founded?

Gynov was founded in 2016.

Which sector is Gynov in?

Gynov operates in Life Sciences Technology.

Who are Gynov's competitors?

Companies similar to Gynov include QuantaCell, Suricog, and MediWAT.